Before the dust has settled from Russia’s rushed deployment of Sputnik V, the vaccine developed by the Gamaleya Institute, Phase 2 trials are now complete for a second COVID-19 vaccine, dubbed EpiVacCorona. In August, Reuters reported that Russia was “preparing” to...